Form D · Pharmaceuticals
COLLEGIUM PHARMACEUTICAL, INC
Stoughton, MA · CIK 0001267565
Offering snapshot reported Nov 13, 2018 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2018 | Initial | $20,000,006 | No comparison | 1 | SEC filing |
| Mar 13, 2015 | Initial | $50,000,000 | No comparison | 18 | SEC filing |
| Oct 2, 2013 | Initial | $4,000,002 | No comparison | 13 | SEC filing |
| Feb 24, 2012 | Initial | $22,461,190 | No comparison | 12 | SEC filing |
| Mar 8, 2010 | Initial | $1,000,000 | No comparison | 7 | SEC filing |
| Jul 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 25, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 19, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 29, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325594
Source: Form D, filed Nov 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Garen Bohlin | Director |
| Paul Brannelly | Executive |
| Joseph Ciaffoni | Director, Executive |
| Scott Dreyer | Executive |
| John A Fallon | Director |
| Alison B. Fleming | Executive |
| Patrick Fortune | Director |
| John Freund | Director |
| Michael Heffernan | Director |
| Patrick Heron | Director |
| David Hirsch | Director |
| Stephen Hoffman | Director |
| Robert W. Jevon | Director |
| Shirley Kuhlmann | Executive |
| Gwen A Melincoff | Director |
| Eran Nadav | Director |
| Gino Santini | Director |
| Theodore Schroeder | Director |
| Matthew Strobeck | Director |
| Steven N. Tannenbaum | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Technology Center Drive
Stoughton, MA, 02072
Stoughton, MA, 02072